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The Zebrafish Kupffer’s Vesicle: 
A Special Organ in a Model 
Organism to Study Human 
Diseases
Mónica Roxo-Rosa and Susana Santos Lopes
Abstract
The Kupffer’s vesicle (KV) is a small, ciliated organ transiently present dur-
ing embryogenesis of the zebrafish and other teleosts. The KV is required to 
the establishment of visceral laterality, such as the heart on the left side, being 
also known by the name left-right organizer (LRO). The LRO is found in other 
vertebrates, including mice, rabbits, frogs and human embryos. Among these, 
the KV became an excellent model organ to investigate the early left-right events 
during development and in disease. Many ciliary molecular players associated to 
the human disease primary ciliary dyskinesia have been tested in the zebrafish 
looking at KV cilia and its downstream effects on flow and left-right markers. 
Additionally, given its morphology and molecular features, we proposed the KV 
as a model organ to study the molecular mechanisms of the renal cyst inflation 
that occurs in the autosomal dominant polycystic kidney disease. Although having 
no connection to the kidney, the KV mimics a renal cyst because it is a fluid-filled 
vesicle, lined by monociliated epithelial cells that express polycystin-2, which 
knockdown leads to the organ luminal enlargement through changes in ion/water 
epithelial transport. Here, we explore the usefulness of the zebrafish KV to model 
these diseases.
Keywords: Kupffer’s vesicle (KV), left-right (LR), left-right organizer (LRO), 
primary ciliary dyskinesia (PCD), autosomal dominant polycystic kidney disease 
(ADPKD)
1. The Kupffer’s vesicle
The KV is an organ transiently present in the early embryonic life of the fish to 
establish internal body laterality [1, 2]. It derives from the dorsal forerunner cells 
(DFCs), a cluster of cells that migrate together from shield developmental stage 
until the end of the epiboly stage during zebrafish development. The DFC cluster 
later forms a lumen, and cilia start to protrude from the cells apically towards the 
new space. Thus, the KV organ will be formed by only one cell layer surrounding 
a lumen (Figure 1). The lumen is also progressively filled with fluid as it opens up 
through a mechanism involving cystic fibrosis transmembrane conductance regula-
tor (CFTR, OMIM-602421), as described before [3–5]. CFTR is a chloride channel 
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which absence or dysfunction causes cystic fibrosis [6–8]. As the KV enlarges, the 
solitary cilium from each KV cell starts to beat, and by ten somite stage (ss), there 
are on average 80% motile cilia and 20% immotile cilia in a total of 60 cells [9]. 
Despite it presents different shapes and sizes, the left-right organizer (LRO) has 
a conserved function among vertebrates, which is to break initial symmetry of 
embryonic body plans. As detailed below there are still many gaps in the develop-
mental process of left-right (LR) establishment that need to be tested. Due to its 
genetic amenability and optical transparency, the zebrafish has gained impact in the 
LR field as one of the best models for testing early LR establishment questions [2, 
9–15]. So far, it is the only animal system where we can manipulate the LRO without 
damaging or sacrificing the animal, thus letting it develop until organ localization 
can be visualized [2]. This allows for causal conclusions to be drawn in the same 
individual fish, which is a powerful advantage in developmental biology.
2. Primary cilia dyskinesia
2.1 The disease
Primary ciliary dyskinesia (PCD) is a rare congenital and heterogeneous dis-
order (OMIM: 244400) with an estimated prevalence of around 1:10 ,000 accord-
ing to Rubbo and Lucas [16], which is thought to be higher in consanguineous 
populations [17]. However, other references in the literature consider a much lower 
prevalence, affecting approximately 1 in 20,000 individuals [18]. It is thought that 
the correct prevalence of the disease is unknown because many patients remain 
undiagnosed. PCD is characterized by a deficient mucociliary clearance, which is 
caused by the lack of motile cilia in the respiratory epithelia, uncoordinated ciliary 
pattern, or a total lack of ciliary motion giving rise to static cilia. PCD leads to 
chronic respiratory infections, and the earlier it is diagnosed, the better prognostic 
the patients will have. Its clinical features usually begin at birth with respira-
tory distress followed by a wet cough in early childhood and evolve to include 
bronchiectasis and chronic sinusitis. In the worst scenario, PCD may lead to lung 
lobectomy [19].
However, PCD is not just a respiratory disease because half of the PCD cases 
are associated with situs inversus and heterotaxy, and in these latter cases, there is 
a high correlation with congenital heart disease [16]. Male sterility is common in 
adults because normal sperm flagella are special motile cilia and in PCD patients 
Figure 1. 
The zebrafish Kupffer’s vesicle. (A) It is imaged from the dorsal side of the embryo in the tail region from 
6 to 14 hours post fertilization (hpf). (B) KV is formed by one layer of monociliated cells. (C) In sox17:GFP 
transgenic line, KV-lining cells are labeled with GFP. (D) Cross section through the KV midplane acquired 
by confocal fluorescent microscopy shows the cilia stained with acetylated alpha-tubulin in green and nuclei 
stained with DAPI in blue.
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may present defective motility. Female ectopic pregnancies have also been reported 
due to the presence of defective motile cilia lining the fallopian tubes [20]. PCD 
usually follows an autosomal recessive inheritance pattern [17].
To date, mutations in more than 35 genes were identified to cause PCD. These 
genes are mainly coding for axonemal proteins that are required for cilia motility or 
for proteins that are needed for the assembly or transport of axonemal components 
[18, 21–23].
Our body is LR asymmetrical. In humans, the heart, spleen, and pancreas are 
localized on the left, while most of the liver and gallbladder are placed on the right 
side of our body axis. The fact that patients with immotile cilia presented defects 
in the location of their internal organs was not obvious to discern and raised many 
questions in the 1970s.
Bjorn Afzelius, who devoted great interest to this topic, postulated that the exis-
tence of an embryonic organ covered by motile ciliated epithelia should explain the 
laterality defects seen in patients with the immotile cilia syndrome [24]. However, 
until today the complete molecular mechanism is still to be fully demonstrated.
2.2 The KV as a model organ to study PCD
Previous early experiments on animal models, namely, in mice mutants named 
inversus viscerum, have shown that mutants that have no ciliary motility in the 
primitive node showed defective situs [25]. Imaging of the mouse nodal cilia 
helped to establish this causal link. These were first imaged in fixed samples by 
performing in situ hybridization with a riboprobe for LR-dynein (lrd) [25]. Soon 
after, mice nodal cilia and nodal flow were filmed and observed in live embryos 
for the first time by Nonaka et al. [26]. These authors compared wild-type (WT) 
embryos with homozygous mutants for KIF3b that formed no cilia and had no nodal 
flow. However, a definitive evidence that the nodal flow was relevant came from 
the elegant experiment, where Nonaka et al. [27] reversed the fluid flow that was 
generated by the nodal motile cilia using an artificial flow in immotile mutants. This 
study revealed that the correct direction of the fluid flow was crucial for the correct 
establishment of LR. Since then many mouse mutants were generated and studied 
[28, 29]. Research on other model organisms, such as frogs and zebrafish, followed 
in order to pursue the molecular mechanisms of laterality (e.g., [2, 30]). Among all 
the models in place, the zebrafish and its KV offer unique advantages to the LR field 
that we will explain and focus here.
The KV is ventrally positioned deep in the embryo, close to the yolk (Figure 1), 
but nevertheless it is accessible for live imaging from the dorsal side. This is only pos-
sible due to its optical clarity. The embryo is extremely transparent allowing filming 
the cilia inside the KV in a live intact zebrafish embryo that is simply mounted in soft 
agarose and embryo medium. This is strikingly different from any other vertebrate 
model. Mice require extracting the embryos at 7.5 days after coitus from the mother’s 
uterus, and then dissected embryos are mounted in a medium prior to removal of 
the Reichert’s membrane that covers the node, to then allow to film the cilia that lay 
inside the node [26]. In Xenopus, it is needed to dissect a frog embryo at stage 14 and 
perform dorsal explant cultures [30]. Therefore, in both these model organisms, the 
manipulations needed to expose the node for live imaging will later lead to the death 
of the animal, before the organs are placed in their asymmetric destinations. This 
problem impedes causal conclusions in the same individuals.
Zebrafish KV, due to its optical properties for live imaging, has been extremely 
useful for the study of nodal flow dynamics (Figure 2). How flow forces could 
trigger the first signals in the KV cells has been intensively explored in this model by 
our lab, both using experimental and theoretical approaches [2, 31–33].
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We focused this review on the LR studies that deal with early events that occur 
in the KV organ. The nature of the signal that is perceived by the KV/node cells 
is not yet resolved. It can still be mechanical or chemical (or both) as debated for 
many years, since the first mouse studies [25, 26, 34]. It is now consensual that fluid 
flow is important, either by its force or by transporting molecules or molecules 
inside extracellular vesicles [34–36].
Zebrafish studies on the speed of flow per KV regions have shown that flow has 
a stereotyped pattern that is biologically relevant for LR establishment [2]. When 
we stopped motility of cilia everywhere except in the right half of the KV, we could 
demonstrate that this led to larva with situs inversus [9]. Although this seems to 
advocate for a mechanosensation process, it is still possible that some chemical 
component exists. For example, secretion of molecules caused by shear stress trig-
gered by the local ciliary beating. This hypothesis is currently under investigation in 
our lab, and it was put forward in a theoretical recent study led by our collaborator 
mathematicians. In this study we predicted the shear stress to be greater on the 
anterior-dorsal side of the KV, mainly caused by the presence of a dorsal cluster of 
cilia [32].
The KV system has also been used to demonstrate that cilia length impacts 
greatly on fluid flow speed [31, 37, 38]. Other labs have also contributed to these 
biophysical characterizations, such as the Amack lab by analyzing the cell shape 
changes that lead to the dorsal cluster of cilia [13], reported earlier by Kreiling 
et al. [39]. The Vermot lab by pioneering the studies on KV flow [40] and recently 
by studying cilia tilt along the 3D KV [12] and its resultant theoretical flow forces. 
Contradictory interpretations emerged from our lab [9] and Vermot lab [12] 
concerning the number of immotile cilia in the KV and the consequent ability 
for the animal to sense flow in a mechanosensory way. This subject needs further 
Figure 2. 
Experimental fluid flow measurements and their different readouts. (A) Native particle tracking where each 
second has a different color to rapidly show where are the slowest regions of flow in the KV. (B) Rayleigh tests 
were performed considering a null hypothesis of a bias distribution toward a given KV quadrant, and p values 
are indicated as green numbers. Note that only particles moving at a distance of r > 0.5 from the center of the 
KVs were considered (r is the normalized distance from the center (r = 0) to the wall (r = 1) of the KV). (C) 
Rose maps show where flow is stronger in a radial manner. (D) Vector maps denote the actual flow forces in a 
vectorial manner. (E) Heat maps of flow speed showing detailed regions within each KV. The pseudocolor scale 
represents flow speed in micrometers per second, where red represents high speed versus low speed in blue. A, 
anterior; P, posterior; R, right; L, left.
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experiments to be solved as our labs used different imaging protocols to determine 
the number of immotile cilia. Another important contribution trying to understand 
the immediate output of the flow came from the Sun and Bruckner labs, where 
Yuan et al. have reported asymmetric intracellular calcium transients that seem to 
be stronger on the left side and become absent upon pkd2 knockdown (the gene 
encoding polycystin 2) [41].
In summary, studies in the KV allowed for the biophysical characterization of 
fluid flow and have shown that disruption of these properties always lead to defec-
tive gene expression of dand5, the first asymmetric gene to appear in zebrafish [35]. 
The expression of dand5 is thought to be dependent on flow forces and will directly 
impact on nodal/spaw later expressed in the lateral plate mesoderm. However, the 
nature of the crucial signal that initiates this conserved genetic cascade is still to be 
demonstrated.
3. Autosomal dominant polycystic kidney disease
3.1 The disease
Autosomal dominant polycystic kidney disease (ADPKD) has been reported 
to affect 1 in 400–1000 newborns worldwide. However, a recent population-
based study in European Union puts ADPKD in the group of rare diseases, 
having an estimated prevalence rate of less than 1 in 2000 individuals [42]. In 
any case, ADPKD is for sure the most common genetic cause of renal failure [42], 
representing a major health problem, with an important socioeconomic impact 
worldwide.
It is caused by mutations in the human genes PKD1 (OMIM-601313) and PKD2 
(OMIM-613095). These encode two ciliary proteins, polycystin-1 and polycystin-2, 
respectively. PKD1 mutations account for about 78% of ADPKD patients and are 
associated with more severe phenotypes. In contrast, a milder disease is observed in 
the patients presenting PKD2 mutations (about 15% of ADPKD patients) [43]. In 
2016, GANAB (OMIM-104160) was identified as a third gene that, when mutated, 
causes ADPKD [44]. This encodes the catalytic α subunit of glucosidase II, a 
resident enzyme of the endoplasmic reticulum involved in the N-glycosylation of 
membrane proteins [44]. Together, PKD1 and PKD2 form a ciliary mechanosensor-
calcium channel complex in the renal epithelium that is essential for the intracel-
lular calcium homeostasis [45, 46]. On the other hand, the glucosidase II subunit 
α is critical for the proper maturation and ciliary versus cell membrane localization 
of both PKD1 and PKD2 proteins [44]. Through not fully understood mechanisms, 
the absence of functional ciliary PKD1/PKD2 complex triggers the formation and 
inexorable expansion of multiple cysts in all segments of the nephrons [45, 46]. 
This ciliopathy also affects other organs and systems. The extrarenal manifestations 
of ADPKD include liver and pancreatic cysts, hypertension, vascular problems, and 
abdominal hernias [43].
The kidney cyst inflation with water and ions and continuous expansion 
throughout the patient life is assured by an abnormal transepithelial fluid secretion 
toward their lumen [47]. CFTR plays a central role in the ADPKD cyst inflation 
[48–53]. Early in the cystogenesis process, CFTR becomes abnormally activated in 
ADPKD cyst-lining cells [48–53]. Supporting the involvement of CFTR in ADPKD 
cyst inflation, it was shown that the fluid accumulation within cysts involves 
CFTR-like chloride currents [53] and it is slowed down either through inhibition or 
knockdown of CFTR [49–53]. Additionally, a milder renal phenotype was observed 
in patients affected by both ADPKD and cystic fibrosis [47].
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The in vivo mechanisms involved in the abnormal activation of CFTR during 
kidney cyst inflation are still emerging. It is known that the lack of calcium homeo-
stasis raises the intracellular levels of cAMP in ADPKD cells [47]. As CFTR activation 
requires its prior cAMP-dependent phosphorylation by PKA [5, 7, 54, 55], it has been 
suggested that CFTR is a downstream effector of the raised levels of cAMP, in cyst 
growth [47]. This led to several studies testing drugs targeting renal cAMP produc-
tion. However, so far only one drug showed an effect in slowing down the enlarge-
ment of cysts in adult ADPKD patients, the Tolvaptan [56]. Acting as a vasopressin V2 
receptor antagonist, Tolvaptan lowers the intracellular cAMP levels of the cyst-lining 
cells and, therefore, the CFTR activity [47].
An evidence is growing that renal cyst formation starts in utero and that 
hypertension in childhood correlated well with disease severity. This is changing 
the old paradigm that considers ADPKD has a late-onset disease [57]. However, 
renal cysts still become clinically detectable only in adulthood, when the disease is 
fully established. The renal volume determination by imaging techniques (ultra-
sound, CT, and T2-weighted NMR scans) is the available tool to assess the disease 
progression. Although the majority of patients remain a- or pauci-symptomatic 
until adulthood, the natural progression of the disease leads to the total destruc-
tion of the renal parenchyma by the countless large cysts. Ultimately, about 50% 
of patients end up requiring renal replacement therapy in their sixth decade of life. 
The recent approval of Tolvaptan in Japan, Canada, and European Union brought 
some hope to patients [48]. However, it shows a moderate effect in slowing down 
the cyst enlargement [56]. Moreover, its side effects include polydipsia, polyuria, 
nocturia, pollakiuria [56], and significant liver enzyme elevation [58] limiting the 
eligible patients to those having <50 years, CKD stages 1–3, and rapidly progress-
ing disease [43]. This means that the identification of biomarkers for the early 
events of ADPKD is an unmet need of the field. These are needed for the early 
diagnosis of the disease and accurate prediction of renal function decline and may 
bring novel therapeutic targets for ADPKD.
There is, therefore, an urgent need to investigate the cellular and biochemical 
pathways involved in kidney cytogenesis with innovative conceptual and method-
ological approaches. In this review, we will put forward the zebrafish model and its 
KV as an unconventional but promising organ model to find such biomarkers.
3.2 The zebrafish pkd genes
The zebrafish genome presents seven pkd and pkd-like genes: pkd1 (also known 
as pkd1a), pkd1b, pkd1l1, pkd1l2a, pkd1l2b, pkd2, and pkd2l1 [59]. In situ hybridiza-
tions showed that both pkd1 and pkd2 are expressed in the zebrafish pronephros at 
24 hpf. In contrast, none of the other five pkd genes were found to be expressed in 
the developing pronephros [59].
The combined knockdown of the paralogues pkd1a and pkd1b, i.e., the orthologues 
of human PKD1, by injection of specific morpholinos against their mRNA which 
specifically block their translation, resulted in dorsal axis curved embryos [60]. An 
identical phenotype was observed by us and others in pkd2 knocked-down embryos 
(pkd2-morphants) (Figure 3) [1, 11, 61, 62]. This phenotype was shown to be associ-
ated with changes in extracellular matrix upon the loss of these polycystins and may 
correlate to the vascular problems observed in ADPKD patients [60]. It ended up to 
being a good control of the efficiency of the knockdown of those genes in the embryo.
Additionally, the knockdown of pkd2 leads to the formation of pronephric dila-
tions which clearly impaired the fluid homeostasis of the animals. Indeed, pkd2 mor-
phants presented severe edema [11, 61, 62]. However, those pronephric dilations did 
not form individualized cystic structures that bud off from the tubules. Although 
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many times named as kidney cysts, these pronephric dilations do not recapitulate 
the vesicular architecture of the ADPKD cysts [11, 61, 62]. On the other hand, the 
available zebrafish pkd2 mutant, the curly-up (cup−/−) mutant, did not develop 
kidney cysts or dilations [11, 62]. Our data suggested that this could be a result of 
the maternal contribution of pkd2 mRNA present during early embryonic stages of 
cup−/− mutants [1]. The combined knockdown of pkd1a and pkd1b also resulted in 
the formation of kidney cysts, but, in this case, the phenotype was observed in only 
10–20% of the embryos [60]. Therefore, we consider the zebrafish pronephros lim-
ited to the study of the molecular mechanisms involved in the ADPKD cystogenesis.
Although KV does not express pkd1a, pkd1b, pkd1l2a, pkd1l2b, or pkd2l1, by in situ 
hybridizations, it was shown that KV cells do express both pkd2 [1, 59] and pkd1l1 [59]. 
Clearly showing the important role of Pkd2 in the LR axis establishment, pkd2 mor-
phant presented laterality defects [1, 11, 62, 63]. Indeed, we showed that 33 and 21% of 
these embryos have right-sided and central hearts, respectively [1]. Schottenfeld and 
co-authors demonstrated that the laterality defects of pkd2 morphants were com-
parable to those observed in cup−/− mutants [11]. Supporting its role in the laterality 
axis establishment, we detected Pkd2 protein expression through the KV-lining cells, 
intracellularly and along their cilia [1]. We now show in Figure 4 that these cells do 
also express Pkd1l1 (polycystin 1 like 1) along their cilia. A similar expression pattern 
was described by Kamura et al. for this gene in the KV of medaka fish [64]. These data 
suggests that the Pkd1l1 is the partner of Pkd2 in the zebrafish KV cells [59], as it was 
also proposed for the medaka KV [64]. Supporting this hypothesis, the lack of pkd1l1 
expression caused laterality defects in medaka embryos [64].
Figure 3. 
Curly-up tail curvature characteristic of pkd2 morphants. Lateral view of WT and pkd2-morphant zebrafish 
embryos at 48 hpf.
Figure 4. 
Confocal images for the immunolocalization of Pkd1l1 in KV cells at the 10–11 ss in WT embryos. Pkd1l1 is 
detected throughout the cells’ cytoplasm and along their cilia. Pkd1l1 is in green and acetylated α-tubulin in 
red. Scale bars: 10 μm.
Zebrafish in Biomedical Research
8
3.3 The KV as a model organ to study the ADPKD cyst inflation
In our perspective, a good model to study the in vivo molecular mechanisms 
involved in the ADPKD cysts inflation should:
1. Be a fluid-filled vesicle.
2. Be lined by ciliated cells that must express Pkd2/Pkd1 and CFTR.
3. Exhibit a physiological fluid flow induced Ca2+-signaling mediated by Pkd2.
4. Depend on CFTR activity for its lumen inflation.
5. Allow the easy knockdown of Pkd2/Pkd1 and CFTR.
6. Allow the easy access to the organ luminal volume.
7. Above all, the knockdown of PKD1/PKD2 must increase the CFTR-
mediated fluid secretion into the lumen, mimicking the ADPKD cyst inflation 
process.
The KV is neither related to the kidney nor to the renal function. However, as it 
fulfills the mentioned requirements, a few years ago we proposed the zebrafish KV 
as a bona fide model organ of the cyst inflation process [1].
As already mentioned, this fluid-filled vesicle organ is lined by monociliated 
cells [1, 2, 9]. The KV cilia are motile and generate a fluid flow that is essential 
for the organ function [2, 9]. These are different from the primary cilia of the 
nephron epithelium or the cilia present in the luminal surface of pkd2WS25/− mice 
ADPKD cysts [65]. Nevertheless, as primary cilia of the nephron segments, the KV 
cilia do express Pkd2 [1]. Interestingly, this channel is crucial for the asymmetric 
intracellular calcium transients that occur in the KV cells [41]. Opposing to the 
renal primary cilia, KV cilia are not expected to express Pkd1 [59]. However, as 
demonstrated in Figure 4, they express Pkd1l1 which is thought to be the Pkd2 
partner in this organ [59, 64]. We expect Pkd1l1 knockdown to cause an abnormal 
LR patterning, similarly to phenotype observed in pkd1l1-medaka morphants [64]. 
By using a morpholino against CFTR, we were able to corroborate the findings of 
Navis et al. [4] showing that the knockdown of CFTR fully impairs the proper KV 
inflation [1].
The transparency of zebrafish embryos makes the KV of transgenic lines 
presenting GFP staining in KV-lining cells accessible by confocal live microscopy 
[1]. These include ras:GFP [1, 66], foxji1:GFP [1, 67], sox17:GFP (Figure 5) [68], 
or TgBAC(cftr-GFP)pd1041 [4] transgenic embryos. In this way, the KV allows the 
measurement of its whole volume as a live readout of CFTR activity, with smaller 
volumes, meaning reduced CFTR activity [1].
The most important feature of the model is the fact that on average the knock-
down of PKD2 leads to ~1.6 times larger KV volumes than the CFTR activation. 
Using a pharmacological approach, we showed that the pkd2 morphants’ KV 
enlargement is assured by a CFTR-mediated fluid secretion into the KV lumen, 
mimicking the ADPKD cyst inflation process [1].
This model was an important innovation in testing drugs that may modulate the 
CFTR-dependent KV inflation. We will publish soon our results with Tolvaptan 
among other drugs. These may give us clues on new drugs that may prevent ADPKD 
cyst enlargement.
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4. Conclusions
The zebrafish KV offers unique features that allow the proper study of the 
in vivo molecular mechanisms of both PCD and ADPKD. In the first disease, the KV 
has already emerged as an ideal system for its uniqueness in allowing to manipulate 
early genes and physical properties and then following up the LR pattern of the 
final organs. In the latter disease, it offers an excellent in vivo model for screen-
ing compounds and genes that may slow down cyst enlargement through CFTR 
inhibition.
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